Lifetime risk of primary total hip replacement surgery for osteoarthritis from 2003-2013

A multi-national analysis using national registry data

Ilana N Ackerman, Megan A Bohensky, Richard de Steiger, Caroline A Brand, Antti Eskelinen, Anne Marie Fenstad, Ove Furnes, Stephen E Graves, Jaason Haapakoski, Keijo Mäkelä, Frank Mehnert, Szilard Nemes, Søren Overgaard, Alma B Pederson, Göran Garellick

Research output: Contribution to journalArticleResearchpeer-review

14 Citations (Scopus)

Abstract

Objective: To compare the lifetime risk of total hip replacement surgery (THR) for osteoarthritis (OA) between countries, and over time.

Methods: Data on primary THR procedures performed for OA in 2003 and 2013 were extracted from national arthroplasty registries in Australia, Denmark, Finland, Norway and Sweden. Life tables and population data were also obtained for each country. Lifetime risk of THR was calculated for 2003 and 2013 using registry, life table and population data.

Results: In 2003, lifetime risk of THR ranged from 8.7% (Denmark) to 15.9% (Norway) for females, and from 6.3% (Denmark) to 8.6% (Finland) for males. With the exception of females in Norway (where lifetime risk started and remained high), lifetime risk of THR increased significantly for both sexes in all countries from 2003 to 2013. In 2013, lifetime risk of THR was as high as 1 in 7 women in Norway, and 1 in 10 males in Finland. Females consistently demonstrated the highest lifetime risk of THR at both time points. Notably, lifetime risk for females in Norway was approximately double the risk for males in 2003 (females: 15.9%, 95% confidence interval (CI) 15.6% to 16.1%; males: 6.9%, 95%CI 6.7% to 7.1%) and 2013 (females: 16.0%, 95%CI 15.8% to 16.3%; males: 8.3%, 95%CI 8.1 to 8.5%).

Conclusion: Using representative, population-based data, this study found statistically significant increases in the lifetime risk of THR in five countries over a 10-year period, and substantial between-sex differences. These multi-national risk estimates can inform resource planning for OA service delivery. This article is protected by copyright. All rights reserved.
Original languageEnglish
Pages (from-to)1659-1667
Number of pages9
JournalArthritis Care and Research
Volume69
Issue number11
DOIs
Publication statusPublished - Nov 2017

Cite this

Ackerman, Ilana N ; Bohensky, Megan A ; de Steiger, Richard ; Brand, Caroline A ; Eskelinen, Antti ; Fenstad, Anne Marie ; Furnes, Ove ; Graves, Stephen E ; Haapakoski, Jaason ; Mäkelä, Keijo ; Mehnert, Frank ; Nemes, Szilard ; Overgaard, Søren ; Pederson, Alma B ; Garellick, Göran. / Lifetime risk of primary total hip replacement surgery for osteoarthritis from 2003-2013 : A multi-national analysis using national registry data. In: Arthritis Care and Research. 2017 ; Vol. 69, No. 11. pp. 1659-1667.
@article{f4b8efab26e14d67a31548e353edb06c,
title = "Lifetime risk of primary total hip replacement surgery for osteoarthritis from 2003-2013: A multi-national analysis using national registry data",
abstract = "Objective: To compare the lifetime risk of total hip replacement surgery (THR) for osteoarthritis (OA) between countries, and over time.Methods: Data on primary THR procedures performed for OA in 2003 and 2013 were extracted from national arthroplasty registries in Australia, Denmark, Finland, Norway and Sweden. Life tables and population data were also obtained for each country. Lifetime risk of THR was calculated for 2003 and 2013 using registry, life table and population data.Results: In 2003, lifetime risk of THR ranged from 8.7{\%} (Denmark) to 15.9{\%} (Norway) for females, and from 6.3{\%} (Denmark) to 8.6{\%} (Finland) for males. With the exception of females in Norway (where lifetime risk started and remained high), lifetime risk of THR increased significantly for both sexes in all countries from 2003 to 2013. In 2013, lifetime risk of THR was as high as 1 in 7 women in Norway, and 1 in 10 males in Finland. Females consistently demonstrated the highest lifetime risk of THR at both time points. Notably, lifetime risk for females in Norway was approximately double the risk for males in 2003 (females: 15.9{\%}, 95{\%} confidence interval (CI) 15.6{\%} to 16.1{\%}; males: 6.9{\%}, 95{\%}CI 6.7{\%} to 7.1{\%}) and 2013 (females: 16.0{\%}, 95{\%}CI 15.8{\%} to 16.3{\%}; males: 8.3{\%}, 95{\%}CI 8.1 to 8.5{\%}).Conclusion: Using representative, population-based data, this study found statistically significant increases in the lifetime risk of THR in five countries over a 10-year period, and substantial between-sex differences. These multi-national risk estimates can inform resource planning for OA service delivery. This article is protected by copyright. All rights reserved.",
author = "Ackerman, {Ilana N} and Bohensky, {Megan A} and {de Steiger}, Richard and Brand, {Caroline A} and Antti Eskelinen and Fenstad, {Anne Marie} and Ove Furnes and Graves, {Stephen E} and Jaason Haapakoski and Keijo M{\"a}kel{\"a} and Frank Mehnert and Szilard Nemes and S{\o}ren Overgaard and Pederson, {Alma B} and G{\"o}ran Garellick",
year = "2017",
month = "11",
doi = "10.1002/acr.23197",
language = "English",
volume = "69",
pages = "1659--1667",
journal = "Arthritis Care and Research",
issn = "2151-464X",
publisher = "Wiley-Blackwell",
number = "11",

}

Ackerman, IN, Bohensky, MA, de Steiger, R, Brand, CA, Eskelinen, A, Fenstad, AM, Furnes, O, Graves, SE, Haapakoski, J, Mäkelä, K, Mehnert, F, Nemes, S, Overgaard, S, Pederson, AB & Garellick, G 2017, 'Lifetime risk of primary total hip replacement surgery for osteoarthritis from 2003-2013: A multi-national analysis using national registry data', Arthritis Care and Research, vol. 69, no. 11, pp. 1659-1667. https://doi.org/10.1002/acr.23197

Lifetime risk of primary total hip replacement surgery for osteoarthritis from 2003-2013 : A multi-national analysis using national registry data. / Ackerman, Ilana N; Bohensky, Megan A; de Steiger, Richard; Brand, Caroline A; Eskelinen, Antti; Fenstad, Anne Marie; Furnes, Ove; Graves, Stephen E; Haapakoski, Jaason; Mäkelä, Keijo; Mehnert, Frank; Nemes, Szilard; Overgaard, Søren; Pederson, Alma B; Garellick, Göran.

In: Arthritis Care and Research, Vol. 69, No. 11, 11.2017, p. 1659-1667.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Lifetime risk of primary total hip replacement surgery for osteoarthritis from 2003-2013

T2 - A multi-national analysis using national registry data

AU - Ackerman, Ilana N

AU - Bohensky, Megan A

AU - de Steiger, Richard

AU - Brand, Caroline A

AU - Eskelinen, Antti

AU - Fenstad, Anne Marie

AU - Furnes, Ove

AU - Graves, Stephen E

AU - Haapakoski, Jaason

AU - Mäkelä, Keijo

AU - Mehnert, Frank

AU - Nemes, Szilard

AU - Overgaard, Søren

AU - Pederson, Alma B

AU - Garellick, Göran

PY - 2017/11

Y1 - 2017/11

N2 - Objective: To compare the lifetime risk of total hip replacement surgery (THR) for osteoarthritis (OA) between countries, and over time.Methods: Data on primary THR procedures performed for OA in 2003 and 2013 were extracted from national arthroplasty registries in Australia, Denmark, Finland, Norway and Sweden. Life tables and population data were also obtained for each country. Lifetime risk of THR was calculated for 2003 and 2013 using registry, life table and population data.Results: In 2003, lifetime risk of THR ranged from 8.7% (Denmark) to 15.9% (Norway) for females, and from 6.3% (Denmark) to 8.6% (Finland) for males. With the exception of females in Norway (where lifetime risk started and remained high), lifetime risk of THR increased significantly for both sexes in all countries from 2003 to 2013. In 2013, lifetime risk of THR was as high as 1 in 7 women in Norway, and 1 in 10 males in Finland. Females consistently demonstrated the highest lifetime risk of THR at both time points. Notably, lifetime risk for females in Norway was approximately double the risk for males in 2003 (females: 15.9%, 95% confidence interval (CI) 15.6% to 16.1%; males: 6.9%, 95%CI 6.7% to 7.1%) and 2013 (females: 16.0%, 95%CI 15.8% to 16.3%; males: 8.3%, 95%CI 8.1 to 8.5%).Conclusion: Using representative, population-based data, this study found statistically significant increases in the lifetime risk of THR in five countries over a 10-year period, and substantial between-sex differences. These multi-national risk estimates can inform resource planning for OA service delivery. This article is protected by copyright. All rights reserved.

AB - Objective: To compare the lifetime risk of total hip replacement surgery (THR) for osteoarthritis (OA) between countries, and over time.Methods: Data on primary THR procedures performed for OA in 2003 and 2013 were extracted from national arthroplasty registries in Australia, Denmark, Finland, Norway and Sweden. Life tables and population data were also obtained for each country. Lifetime risk of THR was calculated for 2003 and 2013 using registry, life table and population data.Results: In 2003, lifetime risk of THR ranged from 8.7% (Denmark) to 15.9% (Norway) for females, and from 6.3% (Denmark) to 8.6% (Finland) for males. With the exception of females in Norway (where lifetime risk started and remained high), lifetime risk of THR increased significantly for both sexes in all countries from 2003 to 2013. In 2013, lifetime risk of THR was as high as 1 in 7 women in Norway, and 1 in 10 males in Finland. Females consistently demonstrated the highest lifetime risk of THR at both time points. Notably, lifetime risk for females in Norway was approximately double the risk for males in 2003 (females: 15.9%, 95% confidence interval (CI) 15.6% to 16.1%; males: 6.9%, 95%CI 6.7% to 7.1%) and 2013 (females: 16.0%, 95%CI 15.8% to 16.3%; males: 8.3%, 95%CI 8.1 to 8.5%).Conclusion: Using representative, population-based data, this study found statistically significant increases in the lifetime risk of THR in five countries over a 10-year period, and substantial between-sex differences. These multi-national risk estimates can inform resource planning for OA service delivery. This article is protected by copyright. All rights reserved.

UR - http://www.scopus.com/inward/record.url?scp=85022170517&partnerID=8YFLogxK

U2 - 10.1002/acr.23197

DO - 10.1002/acr.23197

M3 - Article

VL - 69

SP - 1659

EP - 1667

JO - Arthritis Care and Research

JF - Arthritis Care and Research

SN - 2151-464X

IS - 11

ER -